Results 151 to 160 of about 71,094 (253)
Objectives To evaluate the clinical benefit of faecal microbiota transplantation administered via a single retention enema, as an adjunctive treatment in the management of dogs with chronic enteropathy. Materials and Methods Blinded, randomised controlled trial.
F. Allerton +16 more
wiley +1 more source
Gut-kidney axis: Dysbiosis and renal disease. [PDF]
Salvadori M, Rosso G.
europepmc +1 more source
Maternal brewer's yeast supplementation did not change the milk oligosaccharide (HMO) concentration, but more mothers felt their milk supply was increased, and fewer reported formula use by 6 months postpartum compared to those taking the placebo. This suggests the supplement may support breastfeeding, warranting further investigation in larger trials.
Lili Jia, Louise Brough, Janet L. Weber
wiley +1 more source
Dysregulated eating behaviour and microbiota-based interventions targeting eating disorders and food addiction. [PDF]
Samulėnaitė S +5 more
europepmc +1 more source
Faecal Attraction: 40 Years of Research in Gut Microbiology
ABSTRACT This article summarises the 2025 British Nutrition Foundation Annual Lecture given on 25/11/25. It overviews aspects of research in anaerobic microbiology, principally involving the human gut. Until October 2025, Gibson was Professor of Food Microbiology at the University of Reading.
Glenn R. Gibson
wiley +1 more source
Microecological Interventions against Antibiotic-Induced Dysbiosis and Related Resistome Expansion. [PDF]
Shi Y, Li H.
europepmc +1 more source
Low Weight Loss Response to Incretin Analogs: A Systematic Review
ABSTRACT The development of GLP‐1 and GIP analogs has been a significant breakthrough in type 2 diabetes and obesity pharmacotherapy. However, individual responses to these medications can vary widely. This systematic review examines factors associated with low or no weight loss response to GLP‐1 and GIP analogs. Key predictors of poor response include
Pamela S. Gaskin, Peter S. Chami
wiley +1 more source
Complex interactions of gut-derived short-chain fatty acids in hyperuricemia and gout pathophysiology. [PDF]
Cui Y +5 more
europepmc +1 more source
ABSTRACT Background Gut microbiota‐derived metabolites are emerging as potential mediators between obesity and cardiometabolic conditions. While weight loss interventions modify microbiota composition, their effects on systemic microbial metabolites remain unclear.
Fernando Q. Iorra +5 more
wiley +1 more source
Determination of the Antimicrobial Effects of Synbiotic Kefir Produced from Buffalo Milk Enriched with Galactooligosaccharides and Inulin. [PDF]
Gülbandilar A, Çalişir N, Aksu Mİ.
europepmc +1 more source

